Despite the fact that EMR sales were the lowest for U.S. and Canada-based vendors in the seven years since Orem, Utah-based KLAS began tracking market share data, Epic continued to make gains among large hospitals with its EpicCare Inpatient solution, capturing nearly 40 percent of the new business, according to KLAS.
In the report, which details the wins and losses of acute care EMR vendors at large hospitals (more than 200 beds), KLAS also notes that McKesson and Siemens scored some “unusual wins,” while Cerner saw no net growth in its clinical market share for the first time.
The report — entitled, Physicians, Nurses, and EMR Adoption: Which Solutions are CEOs Betting On? — reflects data collected from more than 1,600 hospitals over 200 beds. While acknowledging the seven-year low in EMR sales, the research also notes that the recent past does not appear to be an indication of the future, as more than 400 were identified that either have no EMR or are using a legacy system. KLAS says it is aware of purchasing activity that, “if the rate continues, will far exceed 2008 sales.”
According to the research, Siemens experienced some notable success, as five non-Siemens hospitals purchase Soarian Clinicals in 2008, despite what KLAS termed its “historically low” CPOE adoption, and won three hospitals in the over 400-bed space. McKesson also made some inroads with larger hospitals; of the 12 McKesson EMR wins in hospitals over 200 beds, four of the organizations chose Paragon Clinicals over Horizon, indicating that Paragon is gaining “significant momentum, not to mention leading performance scoring” in the community HIS market, states KLAS.
For Cerner and Eclipsys, the report noted that leadership in CPOE adoption did not necessarily translate into EMR wins. Despite success both vendors with had in this area, neither was among the top three in new large hospital EMR sales, it says.
Other vendors highlighted in the report include GE, Meditech, Medsphere and QuadraMed.
To purchase the report, healthcare providers and vendors can visit www.KLASresearch.com.